|
|
 |
|
Viewing report
|
|
|
|
Lung Cancer: Global Incidence, Prevalence and Mortality to 2015
Espicom Business Intelligence Ltd, July 2010, Pages: 135
Lung cancer is expected to account for an estimated 12.5% of all new cancer cases in the leading economies in 2010, giving it the second highest incidence, marginally behind colorectal cancer and just ahead of breast and prostate cancers. The publisher estimates that there have been 488,400 new cases of lung cancer in major markets to date in 2010 and projects this number to increase to 536,400 by 2015, a CAGR of 2.9%. The rate of incidence per 100,000 is projected to climb from 66.4 in 2010 to reach 71.4 in 2015. There is a higher incidence of lung cancer amongst the male population. In the seven markets examined, the publisher estimates 300,000 new cases of male lung cancer in 2010, compared to 188,400 in women. With a faster growing rate amongst females the margin is expected to narrow by 2015, with male incidence rising to 314,100 and female incidence climbing to 222,300. The rate of incidence per 100,000 population is expected to climb from 83.3 to 85.3 for males over the 2010 to 2015 period, against an increase of 50.2 to 58.0 for females.
A refreshing and original view of the forward market dynamics for this critical disease area;
In 135 statistics-packed pages, Lung Cancer:Global Incidence, Prevalence & Mortality to 2015 (published July 2010) offers an independent view of the current and future burden of lung cancer in the pharmaceutical markets of the United States, Japan, France, Germany, Italy, Spain and the United Kingdom. Building upon base data derived primarily from national statistical sources, the projections to 2015 are modelled using the publishers proprietary methodology and provide an alternative set of data for analysts to add to their consensus view and base their own market models upon.
Among the data provided...
Incidence
New Cases of Lung Cancer in the Top 7 Countries, 2007-2015
New Lung Cancer cases and Incidence rates in the Top 7 countries will increase steadily between 2007 and 2015
Lung Cancer Incidence as a % of All Cancer Types in the Top 7 Countries, 2007-2015
Lung Cancer Incidence in the Top 7 Countries, 2007-2015 (per 100,000 population)
New Cases of Lung Cancer in the Top 7 Countries - Males, 2010-2015 (000s)
New Cases of Lung Cancer in the Top 7 Countries - Females, 2010-2015 (000s)
New Cases of Lung Cancer in the Top 7 Countries - Males & Females, 2010-2015 (000s)
For France, Germany, Italy, Japan, UK, Spain and the USA
New Cases of Lung Cancer, 2007-2015
Lung Cancer Incidence, 2007-2015
Lung Cancer Incidence as a % of All Cancer Types, 2007-2015
Lung Cancer Incidence in France, 2007-2015 (per 100,000 population)
Lung Cancer Incidence per 100,000 Population - Males, 2010-2015
Lung Cancer Incidence per 100,000 Population - Females, 2010-2015
Lung Cancer Incidence per 100,000 Population - Males & Females, 2010-2015
Prevalence
One- & Five-Year Lung Cancer Prevalence in the Top 7 Countries, 2007-2015
One- & Five-Year Lung Cancer Prevalence in France, 2007-2015
One- & Five-Year Lung Cancer Prevalence in Germany, 2007-2015
One- & Five-Year Lung Cancer Prevalence in Italy, 2007-2015
One- & Five-Year Lung Cancer Prevalence in Spain, 2007-2015
One- & Five-Year Lung Cancer Prevalence in the United Kingdom, 2007-2015
One- & Five-Year Lung Cancer Prevalence in the United States, 2007-2015
One- & Five-Year Lung Cancer Prevalence in Japan, 2007-2015
One- & Five-Year Lung Cancer Relative Survival in the Top 7 Countries, 2010
Mortality
Lung Cancer Mortality in Top 7 Countries, 2007-2015
Lung Cancer Mortality Rates in the Top 7 countries, 2007-2015
Lung Cancer Mortality Rates in the Top 7 Countries - Males, 2010-2015
Lung Cancer Mortality Rates in the Top 7 Countries - Females, 2010-2015
Lung Cancer Mortality Rates in the Top 7 Countries - Males and Females, 2010-2015
For France, Germany, Italy, Japan, UK, Spain and the USA
Deaths from Lung Cancer, 2007-2015
Lung Cancer Mortality, 2007-2015
Lung Cancer Mortality Rates, 2007-2015
Lung Cancer Mortality Rates - Males, 2010-2015
Lung Cancer Mortality Rates - Females, 2010-2015
Number of Deaths and Age-specific Mortality
Rates, Lung Cancer, Females, 2010-2015
Lung Cancer Mortality Rates - Males and Females, 2010-2015
Customers who bought this item also bought
Epidemiology: Non-Small Cell Lung Cancer - Despite global efforts to stop smoking, incidence rates will remain unchanged
Bladder Cancer Therapeutics - Global Strategic Business Report
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
Global Prostate Cancer Therapeutics Market (2010 – 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)
Lung Cancer Vaccines: Pipeline, Strategies and Clinical
Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries.
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical
|
|
|
|
